130 related articles for article (PubMed ID: 15793802)
1. Oral heparin delivery: design and in vivo evaluation of a stomach-targeted mucoadhesive delivery system.
Schmitz T; Leitner VM; Bernkop-Schnürch A
J Pharm Sci; 2005 May; 94(5):966-73. PubMed ID: 15793802
[TBL] [Abstract][Full Text] [Related]
2. pH-responsive thiolated chitosan nanoparticles for oral low-molecular weight heparin delivery: in vitro and in vivo evaluation.
Fan B; Xing Y; Zheng Y; Sun C; Liang G
Drug Deliv; 2016; 23(1):238-47. PubMed ID: 24865290
[TBL] [Abstract][Full Text] [Related]
3. Development and in vivo evaluation of an oral delivery system for low molecular weight heparin based on thiolated polycarbophil.
Kast CE; Guggi D; Langoth N; Bernkop-Schnürch A
Pharm Res; 2003 Jun; 20(6):931-6. PubMed ID: 12817900
[TBL] [Abstract][Full Text] [Related]
4. Design and in vivo evaluation of a patch delivery system for insulin based on thiolated polymers.
Grabovac V; Föger F; Bernkop-Schnürch A
Int J Pharm; 2008 Feb; 348(1-2):169-74. PubMed ID: 17706903
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo investigation of low molecular weight heparin-alginate beads for oral administration.
Iskenderoğlu C; Acartürk F; Erdoğan D; Bardakçi Y
J Drug Target; 2013 May; 21(4):389-406. PubMed ID: 23350807
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic evaluation of an oral tablet form of low-molecular-weight heparin and deoxycholic acid conjugate as a novel oral anticoagulant.
Park JW; Jeon OC; Kim SK; Al-Hilal TA; Lim KM; Moon HT; Kim CY; Byun Y
Thromb Haemost; 2011 Jun; 105(6):1060-71. PubMed ID: 21437357
[TBL] [Abstract][Full Text] [Related]
7. Conjugation of low-molecular-weight heparin and deoxycholic acid for the development of a new oral anticoagulant agent.
Lee Y; Nam JH; Shin HC; Byun Y
Circulation; 2001 Dec; 104(25):3116-20. PubMed ID: 11748110
[TBL] [Abstract][Full Text] [Related]
8. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation.
Paliwal R; Paliwal SR; Agrawal GP; Vyas SP
Int J Pharm; 2012 Jan; 422(1-2):179-84. PubMed ID: 22079712
[TBL] [Abstract][Full Text] [Related]
9. Preparation and evaluation of oral solid heparin using emulsifier and adsorbent for in vitro and in vivo studies.
Ito Y; Kusawake T; Prasad YV; Sugioka N; Shibata N; Takada K
Int J Pharm; 2006 Jul; 317(2):114-9. PubMed ID: 16631328
[TBL] [Abstract][Full Text] [Related]
10. Oligomeric bile acid-mediated oral delivery of low molecular weight heparin.
Al-Hilal TA; Park J; Alam F; Chung SW; Park JW; Kim K; Kwon IC; Kim IS; Kim SY; Byun Y
J Control Release; 2014 Feb; 175():17-24. PubMed ID: 24333628
[TBL] [Abstract][Full Text] [Related]
11. [Oral cavity delivery system of unfractionated and low molecular weight heparin].
Li D; Hou HM
Yao Xue Xue Bao; 2010 Oct; 45(10):1317-21. PubMed ID: 21348313
[TBL] [Abstract][Full Text] [Related]
12. Oral bioavailability of a low molecular weight heparin using a polymeric delivery system.
Hoffart V; Lamprecht A; Maincent P; Lecompte T; Vigneron C; Ubrich N
J Control Release; 2006 Jun; 113(1):38-42. PubMed ID: 16697485
[TBL] [Abstract][Full Text] [Related]
13. Oral delivery of low molecular weight heparin microspheres prepared using biodegradable polymer matrix system.
Lanke SS; Gayakwad SG; Strom JG; D'souza MJ
J Microencapsul; 2009 Sep; 26(6):493-500. PubMed ID: 18846463
[TBL] [Abstract][Full Text] [Related]
14. Papain: an effective permeation enhancer for orally administered low molecular weight heparin.
Grabovac V; Schmitz T; Föger F; Bernkop-Schnürch A
Pharm Res; 2007 May; 24(5):1001-6. PubMed ID: 17372680
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of pegylated dendrimeric nanocarrier for pulmonary delivery of low molecular weight heparin.
Bai S; Ahsan F
Pharm Res; 2009 Mar; 26(3):539-48. PubMed ID: 19034631
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of self-dissolving needles containing low molecular weight heparin (LMWH) in rats.
Ito Y; Murakami A; Maeda T; Sugioka N; Takada K
Int J Pharm; 2008 Feb; 349(1-2):124-9. PubMed ID: 17826015
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of orally active chemical conjugate of low molecular weight heparin and deoxycholic acid in rats, mice and monkeys.
Lee YK; Kim SK; Lee DY; Lee S; Kim CY; Shin HC; Moon HT; Byun Y
J Control Release; 2006 Apr; 111(3):290-8. PubMed ID: 16497407
[TBL] [Abstract][Full Text] [Related]
18. Positively charged polyethylenimines enhance nasal absorption of the negatively charged drug, low molecular weight heparin.
Yang T; Hussain A; Bai S; Khalil IA; Harashima H; Ahsan F
J Control Release; 2006 Oct; 115(3):289-97. PubMed ID: 17023085
[TBL] [Abstract][Full Text] [Related]
19. Tricaprylin microemulsion for oral delivery of low molecular weight heparin conjugates.
Kim SK; Lee EH; Vaishali B; Lee S; Lee YK; Kim CY; Moon HT; Byun Y
J Control Release; 2005 Jun; 105(1-2):32-42. PubMed ID: 15925422
[TBL] [Abstract][Full Text] [Related]
20. Granules in the improvement of oral heparin bioavailability.
Scala-Bertola J; Rabiskova M; Lecompte T; Bonneaux F; Maincent P
Int J Pharm; 2009 Jun; 374(1-2):12-6. PubMed ID: 19446753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
